The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Maternal Outcome After Conservative Treatment of Placenta Accreta
Abstract
OBJECTIVE: To estimate maternal outcome after conservative management of placenta accreta. METHODS: This retrospective multicenter study sought to include all women treated conservatively for placenta accreta in tertiary university hospital centers in France from 1993 to 2007. Conservative management was defined by the obstetrician's decision to leave the placenta in situ, partially or totally, with no attempt to remove it forcibly. The primary outcome was success of conservative treatment, defined by uterine preservation. The secondary outcome was a composite measure of severe maternal morbidity including sepsis, septic shock, peritonitis, uterine necrosis, fistula, injury to adjacent organs, acute pulmonary edema, acute renal failure, deep vein thrombophlebitis or pulmonary embolism, or death. RESULTS: Of the 40 university hospitals that agreed to participate in this study, 25 institutions had used conservative treatment at least once (range 1-46) and had treated a total of 167 women. Conservative treatment was successful for 131 of the women (78.4%, 95% confidence interval [CI] 71.4-84.4%); of the remaining 36 women, 18 had primary hysterectomy and 18 had delayed hysterectomy (10.8% each, 95% CI 6.5-16.5%). Severe maternal morbidity occurred in 10 cases (6.0%, 95% CI 2.9-10.7%). One woman died of myelosuppression and nephrotoxicity related to intraumbilical methotrexate administration. Spontaneous placental resorption occurred in 87 of 116 cases (75.0%, 95% CI 66.1-82.6%), with a median delay from delivery of 13.5 weeks (range 4-60 weeks). CONCLUSION: Conservative treatment for placenta accreta can help women avoid hysterectomy and involves a low rate of severe maternal morbidity in centers with adequate equipment and resources.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conservative expectant management with part of the placenta left in situ was successful in 131 out of 167 cases (78.4%; 95% CI 71.4-84.4).195”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [195]
In the citing paper
“Spontaneous placental resorption occurred in 87 out of 116 cases (75.0%; 95% CI 66.1-82.6), with a median delay from delivery of 13.5 weeks (range 4-60 weeks).195”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [195]
In the citing paper
“However, comparison of these approaches for women with PAS has not been robustly investigated.”
From Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the UK and France: a population‐based comparative study (2022) · cites this paper as [17]
In the citing paper
“Others have used an approach to conserve the uterus where the placenta is left in situ, either partially or completely, without any attempted removal. 17 , 21 This approach is the most common method of conservative management.”
From Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the UK and France: a population‐based comparative study (2022) · cites this paper as [17]
In the citing paper
“However, these studies were not population‐based and lacked an appropriate comparison group.”
From Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the UK and France: a population‐based comparative study (2022) · cites this paper as [17]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Abnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331
Clinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106
Placenta Previa, Placenta Accreta, and Vasa Previa
Oyelese, Y., & Smulian, J. C. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000207559.15715.98 · Cited by 975
Understanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730
Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery
Clark, S. L., Belfort, M. A., Dildy, G. A., Herbst, M. A., Meyers, J. A., & Hankins, G. D. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.03.007 · Cited by 627
The management of placenta percreta: Conservative and operative strategies
O'Brien, J. M., Barton, J. R., & Donaldson, E. S. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70117-5 · Cited by 625
Optimal management strategies for placenta accreta
Eller, A., Porter, T., Soisson, P., & Silver, R. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02037.x · Cited by 578
Conservative Versus Extirpative Management in Cases of Placenta Accreta
Kayem, G., Davy, C., Goffinet, F., Thomas, C., Clément, D., & Cabrol, D. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000136086.78099.0f · Cited by 283
Self-citation
Research works printed but not linked: 2
- 1998, Postpartum hemorrhage. ACOG Educational Bulletin 243.
- 2002, Placenta accreta. ACOG Committee Opinion No. 266. American College of Obstetricians and Gynecologists., Int J Gynecol Obstet, 77, 77
Cited by
Obstetric Care Consensus No. 7: Placenta Accreta Spectrum
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002983 · Cited by 523
Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta
Silver, R. M. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001005 · Cited by 519
Silver, R. M., & Branch, D. W. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709324 · Cited by 511
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
Self-citationCahill, A. G., Beigi, R., Heine, R. P., Silver, R. M., & Wax, J. R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.09.042 · Cited by 481
Metadata
- Authors
- Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., Perrotin, F., Winer, N., Pierre, F., Benachi, A., Dreyfus, M., Bauville, E., Mahieu-Caputo, D., Marpeau, L., Descamps, P., Goffinet, F., & Bretelle, F.
- ORCID
- Venue
- Obstetrics & Gynecology
- Published
- 2010-03
- Volume
- 115
- Issue
- 3
- Pages
- 526-534
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W1979699875
- Cited by
- 515
- References
- 32
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 27 · 2023: 32 · 2022: 44 · 2021: 21 · 2020: 25 · 2019: 39 · 2018: 36 · 2017: 86 · 2016: 21 · 2015: 25 · 2014: 13 · 2013: 33 · 2012: 21
- FWCI
- 25.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Keywords
- placenta accreta, conservative treatment, uterine preservation, hysterectomy, severe maternal morbidity, methotrexate, maternal outcomes
- MeSH terms
- Adult, Embolization, Therapeutic, Female, Postpartum Hemorrhage, Humans, Oxytocics, Placenta Accreta, Pregnancy, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maternal Outcome After Conservative Treatment of Placenta Accreta. https://app.cochat.ai/papers/10.1097/aog.0b013e3181d066d4
- The paper
- Sentilhes, L., Ambroselli, C., Kayem, G., Provansal, M., Fernandez, H., Perrotin, F., Winer, N., Pierre, F., Benachi, A., Dreyfus, M., Bauville, E., Mahieu-Caputo, D., Marpeau, L., Descamps, P., Goffinet, F., & Bretelle, F. (2010). Maternal Outcome After Conservative Treatment of Placenta Accreta. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0b013e3181d066d4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.